Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

In Ku Yo, Oh Sang Kwon, Jin Woong Park, Jong Joon Lee, Jung Hyun Lee, In Sik Won, Sun Young Na, Pil Kyu Jang, Pyung Hwa Park, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim

Clin Mol Hepatol. 2015;21(1):32-40. Published online March 25, 2015

Web of Science 13 Crossref 12

DOI: https://doi.org/10.3350/cmh.2015.21.1.32

Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients

Sang Kyung Jung, Kyung-Ah Kim, So Young Ha, Hyun Kyo Lee, Young Doo Kim, Bu Hyun Lee, Woo Hyun Paik, Jong Wook Kim, Won Ki Bae, Nam-Hoon Kim, June Sung Lee, Yoon Jung Jwa

Clin Mol Hepatol. 2015;21(1):41-48. Published online March 25, 2015

Web of Science 14 Crossref 11

DOI: https://doi.org/10.3350/cmh.2015.21.1.41

Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells

Ha Ra Gu, Su Cheol Park, Su Jin Choi, Jae Cheol Lee, You Cheoul Kim, Chul Ju Han, Jin Kim, Ki Young Yang, Yeon Joo Kim, Geum Youb Noh, So Hyeon No, Jae-Hoon Jeong

Clin Mol Hepatol. 2015;21(1):49-59. Published online March 25, 2015

Web of Science 29 Crossref 28

DOI: https://doi.org/10.3350/cmh.2015.21.1.49

Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma

Hyo Jeong Lee, Hyo Jeong Kang, Kang Mo Kim, Eun Sil Yu, Ki Hun Kim, Seung-Mi Kim, Tae Won Kim, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2015;21(1):60-70. Published online March 25, 2015

Web of Science 21 Crossref 21

DOI: https://doi.org/10.3350/cmh.2015.21.1.60

Alteration of laboratory findings after radiofrequency ablation of hepatocellular carcinoma: relationship to severity of the underlying liver disease and the ablation volume

Sang-Wook Shin, Woo Kyoung Jeong, Sanghyeok Lim, Yongsoo Kim, Jinoo Kim

Clin Mol Hepatol. 2015;21(1):71-79. Published online March 25, 2015

Web of Science 2 Crossref 3

DOI: https://doi.org/10.3350/cmh.2015.21.1.71

Case Reports

A case of primary hepatic actinomycosis: an enigmatic inflammatory lesion of the liver

Yeon Jung Ha, Ji Hyun An, Ju Hyun Shim, Eun Sil Yu, Jong Jae Kim, Tae Yong Ha, Han Chu Lee

Clin Mol Hepatol. 2015;21(1):80-84. Published online March 25, 2015

Web of Science 9 Crossref 8

DOI: https://doi.org/10.3350/cmh.2015.21.1.80

Low-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patient

Jin Ok Kim, Dae Won Jun, Hye Jin Tae, Kang Nyeong Lee, Hang Lak Lee, Oh Young Lee, Ho Soon Choi, Byung Chul Yoon, Joon Soo Hahm

Clin Mol Hepatol. 2015;21(1):85-88. Published online March 25, 2015

Web of Science 12 Crossref 11

DOI: https://doi.org/10.3350/cmh.2015.21.1.85

Liver Pathology

Budd-Chiari syndrome with multiple large regenerative nodules

Haeryoung Kim, Ji Hae Nahm, Young Nyun Park

Clin Mol Hepatol. 2015;21(1):89-94. Published online March 25, 2015

Web of Science 11 Crossref 12

DOI: https://doi.org/10.3350/cmh.2015.21.1.89

Liver Imaging

Recent advances in the imaging of hepatocellular carcinoma

Myung-Won You, So Yeon Kim, Kyoung Won Kim, So Jung Lee, Yong Moon Shin, Jin Hee Kim, Moon-Gyu Lee

Clin Mol Hepatol. 2015;21(1):95-103. Published online March 25, 2015

Web of Science 6 Crossref 7

DOI: https://doi.org/10.3350/cmh.2015.21.1.95

Erratum

Erratum

Clin Mol Hepatol. 2015;21(1):104-104. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.104
Corrects: Clin Mol Hepatol 2014;20(4):355

Viewed By 5145	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5007	MAFLD: How is it different from NAFLD?
Viewed By 4914	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3641	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3583	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 67	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 51	MAFLD: How is it different from NAFLD?

Previous issues